Movement Alert｜Twist Bioscience Rises 5.59% in Regular Trading, Investment Bank Raises Target Price to $90

Market Focus06-15

On June 15, Twist Bioscience rose 5.59% in regular trading, trading at $80.35/share, with turnover of $51.52 million.

On the news front, Canaccord Genuity issued a buy rating on Twist Bioscience with a target price of $90, implying approximately 12% upside from the current price level. According to FactSet data, the stock carries an average analyst rating of buy with a mean target price of $73.12. The Canaccord Genuity target significantly exceeds the market consensus level, providing a clear near-term catalyst for the stock.

Twist Bioscience is a synthetic biology platform company that has developed a disruptive silicon-based DNA synthesis technology. The company serves customers across healthcare, food and agriculture, industrial chemicals, academic research, and data storage markets. The company reported its most recent quarterly earnings on May 4, posting an EPS of -$0.62. Despite ongoing losses, the elevated target price from Canaccord Genuity reflects confidence in the company's long-term growth trajectory and commercial potential across its diversified end markets.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1128802206?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-15 23:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1128802206","market":"us","top_or_hot":-1,"title":"Movement Alert｜Twist Bioscience Rises 5.59% in Regular Trading, Investment Bank Raises Target Price to $90","media":"Market Focus","content":"<p><p>On June 15, Twist Bioscience rose 5.59% in regular trading, trading at $80.35/share, with turnover of $51.52 million.</p><p>On the news front, Canaccord Genuity issued a buy rating on Twist Bioscience with a target price of $90, implying approximately 12% upside from the current price level. According to FactSet data, the stock carries an average analyst rating of buy with a mean target price of $73.12. The Canaccord Genuity target significantly exceeds the market consensus level, providing a clear near-term catalyst for the stock.</p><p>Twist Bioscience is a synthetic biology platform company that has developed a disruptive silicon-based DNA synthesis technology. The company serves customers across healthcare, food and agriculture, industrial chemicals, academic research, and data storage markets. The company reported its most recent quarterly earnings on May 4, posting an EPS of -$0.62. Despite ongoing losses, the elevated target price from Canaccord Genuity reflects confidence in the company's long-term growth trajectory and commercial potential across its diversified end markets.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Twist Bioscience Rises 5.59% in Regular Trading, Investment Bank Raises Target Price to $90</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Twist Bioscience Rises 5.59% in Regular Trading, Investment Bank Raises Target Price to $90\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-15 23:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 15, Twist Bioscience rose 5.59% in regular trading, trading at $80.35/share, with turnover of $51.52 million.</p><p>On the news front, Canaccord Genuity issued a buy rating on Twist Bioscience with a target price of $90, implying approximately 12% upside from the current price level. According to FactSet data, the stock carries an average analyst rating of buy with a mean target price of $73.12. The Canaccord Genuity target significantly exceeds the market consensus level, providing a clear near-term catalyst for the stock.</p><p>Twist Bioscience is a synthetic biology platform company that has developed a disruptive silicon-based DNA synthesis technology. The company serves customers across healthcare, food and agriculture, industrial chemicals, academic research, and data storage markets. The company reported its most recent quarterly earnings on May 4, posting an EPS of -$0.62. Despite ongoing losses, the elevated target price from Canaccord Genuity reflects confidence in the company's long-term growth trajectory and commercial potential across its diversified end markets.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TWST","symbol_name":"Twist Bioscience Corp","start_time":0,"source_url":"","article_id":"1128802206","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1128802206","pubTimestamp":1781535812,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 15, Twist Bioscience rose 5.59% in regular trading, trading at $80.35/share, with turnover of $51.52 million.On the news front, Canaccord Genuity issued a buy rating on Twist Bioscience with...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TWST":"Twist Bioscience Corp"},"translate_title":"动向提示|Twist Bioscience常规交易涨5.59%投行上调目标价至90美元","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TWST":1},"content_text":"On June 15, Twist Bioscience rose 5.59% in regular trading, trading at $80.35/share, with turnover of $51.52 million.On the news front, Canaccord Genuity issued a buy rating on Twist Bioscience with a target price of $90, implying approximately 12% upside from the current price level. According to FactSet data, the stock carries an average analyst rating of buy with a mean target price of $73.12. The Canaccord Genuity target significantly exceeds the market consensus level, providing a clear near-term catalyst for the stock.Twist Bioscience is a synthetic biology platform company that has developed a disruptive silicon-based DNA synthesis technology. The company serves customers across healthcare, food and agriculture, industrial chemicals, academic research, and data storage markets. The company reported its most recent quarterly earnings on May 4, posting an EPS of -$0.62. Despite ongoing losses, the elevated target price from Canaccord Genuity reflects confidence in the company's long-term growth trajectory and commercial potential across its diversified end markets.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1128802206","isCrawlerRequest":true}